Literature DB >> 35259171

Is lack of health insurance a predictor of worsening of heart failure among adult patients attending referral hospitals in Northwestern Tanzania?

Bahati M K Wajanga1,2, Christine Yaeree Kim3, Robert N Peck1,2,4,5, John Bartlett6,7,8, Deodatus Mabula1,2, Adinan Juma8, Charles Muiruri6,7,8.   

Abstract

INTRODUCTION: Health insurance coverage is critical for persons living with chronic conditions such as heart failure. Lack of health insurance may affect the ability to access regular healthcare appointments, pay for medication refills which can result in frequent hospitalization that is associated with poor clinical outcomes. In scarce resource locations such as sub-Saharan Africa, where uptake of health insurance is still suboptimal, the effect of health insurance on chronic conditions such as heart failure is poorly understood. The objective of this study was to assess the association of health insurance on the severity of heart failure for patients attending outpatient clinics at tertiary hospitals in Mwanza, Tanzania.
METHODS: As part of a larger cohort study, patients with heart failure were recruited from Bugando Medical Center (BMC) and Sekou Toure Regional Hospital (STRH) in Mwanza City, Tanzania. Heart failure was based on Framingham criteria and the severity was determined by New York Heart Association (NYHA) classification. Descriptive analysis and multivariable logistic regression were used to describe the study participants and to assess the association between health insurance status and the severity of heart failure at baseline.
RESULTS: 418 patients were enrolled, and majority were female (n = 264, 63%), small scale farmers (n = 278, 66.5%) and were from Mwanza City (n = 299, 71.5%). More than two-thirds of patients did not have health insurance (n = 295, 70.6%) and the majority were in the NYHA I and II classification (n = 267, 64.7%). There was no association between health insurance status and the severity of heart (aOR 0.97; 95% CI 0.84-1.60). Being male, small-scale businessperson and those seen at STRH was associated with higher odds of being in NYHA Class III/IV (aOR = 1.97; 95% CI: 1.21-3.17), (aOR = 2.61; 95% CI: 1.27-5.34) and (aOR 1.91 95% CI: 1.17-3.13) respectively. Having secondary and college education was associated with lower odds of being in Class III/IV (0.42; 95% CI: 0.18-0.98) and (aOR = 0.23 95% CI: 0.06-0.86) respectively.
CONCLUSION: In this study, only a third of the patients had health insurance. Health insurance was not associated with the severity of heart failure. Since heart failure is a chronic condition patients who do not have health insurance may incur out of pocket expenses, future research should focus on the effect of out-of-pocket expenditures on clinical outcomes.

Entities:  

Mesh:

Year:  2022        PMID: 35259171      PMCID: PMC8903262          DOI: 10.1371/journal.pone.0264352

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.752


Introduction

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality globally, accounting for 17.9 million deaths in 2016—or 44% of all deaths from non-communicable diseases (NCDs) globally [1]. The burden of CVD is growing at an alarming pace in low- and middle-income countries, especially in Sub-Saharan Africa (SSA) [1]. Among CVDs, heart failure in SSA is associated with high rates of rehospitalization, poor quality of life and high mortality [2, 3]. For example, prospective cohort studies of heart failure at two large hospitals in Tanzania reported 1-year mortality rates of more than 20% [4, 5]. The burden of undiagnosed heart failure in SSA continues to rise, especially in rural areas; delayed diagnosis leads to late presentation and greater the severity of disease which in turn creates more economic burden for patients [6-8]. In SSA, it is estimated that 3–7% of all admissions to hospitals are due to heart failure, and governments spent around 1% of their total budget for management of heart failure [9, 10]. In countries without universal health coverage, costs of care for heart failure may expose patients and their families to financial hardship [11]. Huffman et al. demonstrated that the lack of health insurance for patients with heart failure resulted in catastrophic spending as high as 92% of individual income. In this study, catastrophic spending was high in all income groups and was associated with a two-fold increase for those in rural areas [12]. Health insurance coverage may improve access to higher quality care with reduced out-of-pocket costs [13]. In Tanzania, only 30% of the total population of 50 million people have access to health insurance [14]. The most commonly used health insurance plan schemes are run by the government including Community Health Fund (CHF) and National Health Insurance (NHIF). These health insurance plans cover 20% of general population. Private insurance plans (e.g., Strategy, Jubilee, AAR and Resolution) cover 1% of general population [15]. Hertz et al. reported that lack of insurance is likely to drive poor health-seeking habits and care delays for patients with CVD [16]. Since heart failure is a chronic condition requiring regular follow up, uninsured patients may struggle to cover out of pocket costs like regular doctor visits and lifelong medication refills, resulting in poor adherence and poor outcomes [17, 18]. However, the effect of health insurance on heart failure outcomes has not been well studied in Tanzania. Identifying individual and societal predictors of heart failure outcomes is an important first step in the development of interventions to reduce heart failure morbidity and mortality. Thus, the objective of this study was to assess the association of patient characteristics and health insurance coverage on the severity of heart failure for patients.

Methods

Participants of this study were recruited from hypertensive and cardiac Clinics of Bugando Medical Center (BMC) and Sekou Toure Regional Hospital (STRH). BMC is one of the 5 zonal referral hospitals in Tanzania with a catchment area of 14 million people. It is located in Mwanza City, the second largest urban center in Tanzania with 950 in-patient beds and approximately 300,000 hospitalizations per year. BMC has a dedicated cardiac clinic that cares for approximately 1400 patients every month. Sekou Toure Hospital is a regional referral hospital of Mwanza region with 300 beds capacity. On average, 320 patients are seen every month at the medical outpatient clinic at STRH. Adults with 18 years of age or older who had heart failure based on Framingham criteria and attending outpatient clinics at BMC and STRH who were fluent in Kiswahili and capable of providing written informed consent were enrolled in the study. During enrollment, a standardized questionnaire was administered in Kiswahili to capture the demographic data, insurance status, functional class of heart failure based on New York Heart Association (NYHA) criteria.

Data analysis

Data were analyzed using Stata statistical software version 15 (StataCorp, College Station, TX). Our primary objective was to determine factors that contributed to severity of heart failure. We used NYHA classification to ascertain the severity of heart failure. The New York Heart Association (NYHA) Classification provides a simple way of classifying the extent of heart failure. It classifies patients in one of four categories based on their limitations of performing physical activity; the limitations/symptoms are in regard to normal breathing and varying degrees in shortness of breath and or angina pain. When the classes move from one to four, this means that the patient has an advanced stage of heart failure, as summarized below. Class I—No symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc. Class II—Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity. Class III—Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20–100 m). Comfortable only at rest. Class IV—Severe limitations [19] We computed a binary outcome variable of the NYHA by merging Class I with Class II and Class III with Class IV. This categorization was deemed appropriate since higher NYHA functional class are predictive of poor outcome in patients with chronic heart failure compare to lower ones. Health insurance status was determined prior to diagnosis of heart failure. We described the study population using descriptive statistics: frequencies and proportions were calculated for categorical variables. Controlling for participants characteristics, multivariable logistic regression was used to assess the association between severity of heart failure (NYHA classification) and health insurance status. We used complete case analysis for missing data [22]. This means we only used cases in the dataset for which there were no missing values. All associations were presented as adjusted odds ratios (aORs) with 95% confidence intervals (CIs). Statistical significance was set at a critical level of P < .05.

Ethical issues

Ethical approval was obtained from the research and ethics committee of BMC (IRB certificate No. CREC/122/2016). All study participants were informed about the study by a study coordinator fluent in Kiswahili and provided written informed consent before participation

Results

418 patients were enrolled in the cohort study. The majority of patients were female (n = 264, 63%), small scale farmers (n = 278, 66.5%), came from Mwanza City (n = 299, 71.5%). More than two-thirds of patients did not have health insurance (n = 295, 70.6%) and the majority were in the NYHA I and II classification (n = 267, 64.7%) as presented in Table 1 below.
Table 1

Demographic characteristics of 418 heart failure patients at BMC and STRH outpatient clinic in Mwanza, Tanzania.

CharacteristicNumber(Percentage)
Sex
    Female264 (63%)
    Male154 (37%)
Age
    18–39 years51 (12.2%)
    40–64 years165 (39.5%)
    > = 65 years202 (48.3%)
Education level
    No formal education86 (20.6%)
    Primary education225 (53.8%)
    Secondary education81 (19.3%)
    College26 (6.2%)
Occupation
    Small- scale farmer278 (66.5%)
    Small-scale business57 (13.6%)
    Employed53 (12.7%)
    Retired30 (7.2%)
Residence
    Mwanza299 (71.5%)
    Outside Mwanza119 (28.5%)
Outpatient Clinic Site
    BMC261 (62.4%)
    STRH157 (37.6%)
Health insurance Status
    Yes123 (29.4%)
    No295 (70.6%)
NYHA Class
    I & II267 (64.7%)
    III & IV146 (35.3%)
We found no association between health insurance status and severity of heart failure as classified by the NYHA (aOR 0.97; 95% CI 0.84–1.60). Being male compared to female was associated with higher odds of being in NYHA Class III/IV (aOR = 1.97; 95% CI: 1.21–3.17). Having secondary and college education compared to no formal education was associated with lower odds of being in Class III/IV (0.42; 95% CI: 0.18–0.98) and (aOR = 0.23; 95% CI: 0.06–0.86) respectively. Being small-scale businessperson compared to small-scale farmer was associated with higher odds being in NYHA Class III/IV (aOR = 2.61; 95% CI: 1.27–5.34). Heart failure patients seen at STRH had higher odds of being in Class III/IV (aOR 1.91; 95% CI: 1.17–3.13) as presented in Table 2 below.
Table 2

Association between NYHA classification and health insurance status for heart failure patients in outpatient clinics at BMC and STRH in Mwanza, Tanzania.

NYHA classification
CharacteristicsI&IIIII&IVBivariateMultivariable
Health insuranceOR95%CIaOR95%CIP-value
    No182(62.5)109(37.5)1.01.0
    Yes85(69.7)37(30.3)0.730.46–1.141.250.72–2.170.17
Sex
    Female178(67.9)84(32.1)1.01.0
    Male89(58.9)62(41.1)1.480.97–2.231.97*1.21–3.190.0065
Age
    18–39 years37(72.5)14(27.5)1.01.0
    40–64 years105(64.4)58(35.6)1.460.79–3.081.640.74–3.19
    > = 65 years125(62.8)74(37.2)1.560.96–3.421.570.66–3.740.43
Education level
    No formal education48(56.5)37(43.5)1.01.0
    Primary education21(80.8)5(19.2)0.770.47–1.290.590.33–1.05
    Secondary education139(62.6)83(37.4)0.460.24–0.890.42*0.18–0.98
    College59(73.7)21(26.25)0.310.11–0.890.23*0.06–0.860.03*
Occupation
    Small- scale farmer175(62.6)100(36.4)1.01.0
    Small-scale business29(51.8)27(48.2)1.630.91–2.902.61*1.27–5.34
    Employed39(75.0)13(25.0)0.580.29–1.140.890.36–2.21
    Retired24(80.0)6(20.0)0.440.17–1.100.620.21–1.860.02*
Outpatient clinic site
    BMC180(70.0)77(30.0)1.0
    STRH87(55.8)69(44.2)1.851.23–2.801.91*1.17–3.130.003**
Residence
    Mwanza187(63.2)109(36.8)1.01.0
    Outside Mwanza80(68.4)37(31.6)0.790.50–1.250.980.59–1.630.32

*** p<0.01

** p<0.05

* p<0.1 AOR: Adjusted Odd Ratio.

*** p<0.01 ** p<0.05 * p<0.1 AOR: Adjusted Odd Ratio.

Discussion

Health insurance coverage is critical in reducing barriers to access, cost and quality of care [13]. Health insurance coverage may be even more crucial for patients with heart failure since these patients require close follow up in order to reduce morbidity and mortality. In this study, we did not find a significant difference in the severity of heart failure for those who had health insurance and those who did not. Mansi et al. found that the presence of health insurance or type of coverage was not a significant predictor of any clinical outcomes for heart failure [20]. Our results may reflect the underlying contribution of behavioral and biological factors that are associated with adverse health outcomes. Pincus et al. observed that poor clinical outcomes resulted were better predicted by social conditions than access to care that is necessitated by health insurance coverage. In this study, other factors found to be associated with severity of heart failure included sex, education, occupation, and hospital site. Poorer heart failure outcomes have been associated with sociodemographic factors including gender, income level, employment status, and educational attainment. Male gender compared to female was associated with higher odds of having severe form of heart failure. This is not surprising since men are less likely to utilize healthcare services than women [22, 23]. This denies them an opportunity for early control of common cardiovascular diseases like hypertension, resulting in later complications like advanced heart failure. Future research should focus on interventions targeted to men who have heart failure. Having secondary and college education was associated with lower odds of having more severe heart failure. This association between education and heart failure outcomes has been observed in other studies from outside sub Saharan Africa [24]. A higher level of education may assist patient understanding of the need for adherence to heart failure medication and adherence to care, and this may in turn slow the progression of disease. Future studies should focus on tailoring interventions to accommodate patients with low levels of education. Finally, being seen at the referral hospital (BMC) compared to the community hospital had higher odds of having severe heart failure. This is because BMC has more organized cardiac clinic with modern equipment and enough expert to take care of patients with cardiovascular conditions compared to Sekou Toure regional referral hospital. These findings should be interpreted in light of the study’s limitations. First, although combining NYHA I with II and III with IV may have meaningful clinical application, these groupings may have obscured the unobserved characteristics between different classes and therefore may have affected the efficiency of the estimator. Second, study participants came from a single district in Tanzania and therefore results may not be generalizable to the entire country. Finally, our results may have been confounded due to the lack of time since initial diagnosis of heart failure. This is because heart failure is likely to progress in severity over time. Notwithstanding these limitations, our findings have policy implications. Our results suggest that a focus on health insurance coverage to increase access to healthcare may not lead to better outcomes for heart failure. Indeed, interventions to reduce heart failure morbidity may need to focus on other patient characteristics, such as health literacy and sex, which appear to be important determinants of health. Contextual factors of specific healthcare facilities may also determine heart failure outcomes. As policy makers consider universal health coverage for their citizens, consideration should be given to other factors that facilitate optimal health.

Transfer Alert

This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present. 5 Nov 2021
PONE-D-21-28263
Is Lack Of Health Insurance Associated With The Severity Of Heart Failure In Northwestern Tanzania?
PLOS ONE Dear Dr. Wajanga, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Dec 20 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Sreeram V. Ramagopalan Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf  and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Please consider changing the title so as to meet our title format requirement (https://journals.plos.org/plosone/s/submission-guidelines). In particular, the title should be "Specific, descriptive, concise, and comprehensible to readers outside the field" and in this case it is not informative and specific about your study's scope, methodology, and findings. 3. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. 4. Thank you for stating the following in the Acknowledgments Section and Funding Sections of your manuscript: Acknowledgement: “The authors wish to thank MEPIJF Tanzania for its financial support. We appreciate the support provided by the Administration of Bugando Referral, Consultant and University Teaching Hospital, and Sekou Toure Regional Referral Hospitals We are grateful to the research team, Dr. Alphonce Ngerecha and Dr. Charles Kitundu.” Funding: “Research reported in this publication was supported by the Fogarty International Center (and list ALL co-funding partners) of the National Institutes of Health under Award Number D43 TW010138.  The contentis solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.” We note that you have provided additional information within the Acknowledgements Section that is not currently declared in your Funding Statement. Please note that funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: “This study was funded by The Medical Education Partnership Initiative-Tanzania (MEPI-T) a collaboration between Weill Cornell Medical College, Duke University, the Kilimanjaro Christian Medical University (KCMU College), and the Weill-Bugando Medical College of the Catholic University of Health and Allied Sciences (CUHAS) to support research training of junior faculty. NO- The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.” Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 5. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ. 6.  Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript. 7. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability. Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized. Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access. We will update your Data Availability statement to reflect the information you provide in your cover letter. 8. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The study investigates the relationship between health insurance coverage and severity of heart failure based on a sample of 418 patients enrolled at two outpatient clinics in Mwanza, Tanzania. Using multivariable logistic regression, no association was found between having health insurance and heart failure severity (NYHA classification III-IV vs. I-II). However, heart failure severity was associated with male sex, lower educational level, small scale business occupation, and treating clinic. The authors discuss how the results may reflect underlying social and biological factors contributing to clinical outcomes, however, on the question of health insurance coverage, call for further research into the impact of out-of-pocket expenses to assess what impact this has on clinical outcomes. Overall, the reporting of the article is clear, well written and the interpretation of findings are reasonable and generally supported by the data. Some points for consideration – 1.The analysis is cross-sectional in design, and the relationship between the exposure (health insurance) and outcome (heart failure severity) is considered, without mention of the temporality between the two variables. It would help to clarify – Whether patients with insurance, had insurance, before the diagnosis of heart failure, or whether its possible some patients could have taken out insurance after the diagnosis of heart failure? To what extent the population comprises patients with prevalent pre-existing heart failure or patients with incident new diagnoses of heart failure? Since heart failure is likely to progress in severity over time, I would suspect time since diagnosis might be an important confounding factor of the outcome to consider. 2.In the Data Analysis section, I would suggest providing more details on the NYHA score to assist readers who are unfamiliar with the measure i.e. the range of the score, and how it is interpreted, i.e. class I = no symptoms/limitations up to class IV= severe symptoms. 3.There is no mention of missing data, the extent and how this was handled in analysis – presume complete case analysis was used. Furthermore in table 2, ideally two columns should be added for the number of patients and events per category to assess whether null associations could be due to insufficient endpoints/power. 4.Line 149-150: “Pincus, et al observed that poor clinical outcomes resulted were better predicted by social conditions than access to care that is necessitated by health insurance coverage.” Check sentence for typo ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
21 Dec 2021 1. PLOS ONE STYLE OF MANUSCRIPT Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates Response Thank you for your feedback. We have revised the current version to meet the PLOS ONE’s style requirement. 2. CHANGING OF TITLE Please consider changing the title so as to meet our title format requirement (https://journals.plos.org/plosone/s/submission-guidelines). In particular, the title should be "Specific, descriptive, concise, and comprehensible to readers outside the field" and in this case it is not informative and specific about your study's scope, methodology, and findings Response: We appreciate your guidance and have revised the current title to read “Is lack of Heath Insurance a predictor of worsening of heart failure among adult patients attending referral hospitals in Northwestern Tanzania?” The short title is “Association of health insurance as a predictor of worsening heart failure” 3. GRANT INFORMATION We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. Response: We apologize for the mistake and have provided the correct grant number in the funding information 4. ACKNOWLEDGEMENT AND FUNDING SECTIONS We note that you have provided additional information within the Acknowledgements Section that is not currently declared in your Funding Statement. Please note that funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Response: Thank you for feedback. We have removed the funding information in the manuscript as per your instruction. 5. ORCID ID PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager Response: Thank you for the feedback. I have included my ORCID ID, which is 0000-0002-1922-0746 6. ETHICS STATEMENT Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript Response: In the current version of the manuscript, we have included the ethics statement in the methods section on line 129-131 7. DATA AVAILABILITY STATEMENT In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter Response Thank you for your feedback. The data set have been uploaded and URL included in the cover letter 8. REFERENCE LIST Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice Response: We reviewed the reference list and have an updated one in this version. Reviewer #1 The study investigates the relationship between health insurance coverage and severity of heart failure based on a sample of 418 patients enrolled at two outpatient clinics in Mwanza, Tanzania. Using multivariable logistic regression, no association was found between having health insurance and heart failure severity (NYHA classification III-IV vs. I-II). However, heart failure severity was associated with male sex, lower educational level, small scale business occupation, and treating clinic. The authors discuss how the results may reflect underlying social and biological factors contributing to clinical outcomes, however, on the question of health insurance coverage, call for further research into the impact of out-of-pocket expenses to assess what impact this has on clinical outcomes. Overall, the reporting of the article is clear, well written and the interpretation of findings are reasonable and generally supported by the data. Some points for consideration – 1.The analysis is cross-sectional in design, and the relationship between the exposure (health insurance) and outcome (heart failure severity) is considered, without mention of the temporality between the two variables. It would help to clarify – Whether patients with insurance, had insurance, before the diagnosis of heart failure, or whether its possible some patients could have taken out insurance after the diagnosis of heart failure? Response: Thank you for your feedback. For this study, we asked about insurance status at the beginning of the study. The patients in this study had insurances prior the diagnosis of heart failure. We have added the description on lines 121-122 To what extent the population comprises patients with prevalent pre-existing heart failure or patients with incident new diagnoses of heart failure? Since heart failure is likely to progress in severity over time, I would suspect time since diagnosis might be an important confounding factor of the outcome to consider. Response: We agree that time since diagnosis of heart failure might be an important confounding factor. Since we did not collect this information in this study, we have declared this limitation on page line 187-189 variable, but then this would work best in a known cohort, followed over time, which was not in our case where the subject was seen once. 2. In the Data Analysis section, I would suggest providing more details on the NYHA score to assist readers who are unfamiliar with the measure i.e. the range of the score, and how it is interpreted, i.e. class I = no symptoms/limitations up to class IV= severe symptoms. Response: We have provided more details about NYHA in the data analysis section lines 106- 118 3. There is no mention of missing data, the extent and how this was handled in analysis – presume complete case analysis was used. Furthermore in table 2, ideally two columns should be added for the number of patients and events per category to assess whether null associations could be due to insufficient endpoints/power. Response: We included a description of how we handled missing data on lines 125-127 We appreciate your feedback and added the two columns. 4. Line 149-150: “Pincus, et al observed that poor clinical outcomes resulted were better predicted by social conditions than access to care that is necessitated by health insurance coverage.” Check sentence for typo Response Thank you. We have corrected the typo. 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public Response We do not need to publish peer review history. Submitted filename: Response to Reviewers.docx Click here for additional data file. 9 Feb 2022 Is lack of Heath Insurance a predictor of worsening of heart failure among adult patients attending referral hospitals in Northwestern Tanzania? PONE-D-21-28263R1 Dear Dr. Wajanga, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Sreeram V. Ramagopalan Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: 18 Feb 2022 PONE-D-21-28263R1 Is lack of Heath Insurance a predictor of worsening of heart failure among adult patients attending referral hospitals in Northwestern Tanzania? Dear Dr. Wajanga: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Sreeram V. Ramagopalan Academic Editor PLOS ONE
  19 in total

1.  Heart failure in Tanzania and Sweden: Comparative characterization and prognosis in the Tanzania Heart Failure (TaHeF) study and the Swedish Heart Failure Registry (SwedeHF).

Authors:  Abel Makubi; Camilla Hage; Ulrik Sartipy; Johnson Lwakatare; Mohammed Janabi; Peter Kisenge; Ulf Dahlström; Lars Rydén; Julie Makani; Lars H Lund
Journal:  Int J Cardiol       Date:  2016-06-29       Impact factor: 4.164

2.  Educational level and the quality of life of heart failure patients: a longitudinal study.

Authors:  Giorgio Barbareschi; Robbert Sanderman; Ivonne Lesman Leegte; Dirk J van Veldhuisen; Tiny Jaarsma
Journal:  J Card Fail       Date:  2011-01       Impact factor: 5.712

3.  Heart failure in sub-saharan Africa: time for action.

Authors:  Albertino Damasceno; Gad Cotter; Anastase Dzudie; Karen Sliwa; Bongani M Mayosi
Journal:  J Am Coll Cardiol       Date:  2007-10-23       Impact factor: 24.094

Review 4.  Social conditions and self-management are more powerful determinants of health than access to care.

Authors:  T Pincus; R Esther; D A DeWalt; L F Callahan
Journal:  Ann Intern Med       Date:  1998-09-01       Impact factor: 25.391

5.  Unaffordable drug prices: the major cause of non-compliance with hypertension medication in Ghana.

Authors:  Kwame Ohene Buabeng; Lloyd Matowe; Jacob Plange-Rhule
Journal:  J Pharm Pharm Sci       Date:  2004-11-12       Impact factor: 2.327

6.  Predominance of heart failure in the Heart of Soweto Study cohort: emerging challenges for urban African communities.

Authors:  Simon Stewart; David Wilkinson; Craig Hansen; Vinesh Vaghela; Robert Mvungi; John McMurray; Karen Sliwa
Journal:  Circulation       Date:  2008-11-24       Impact factor: 29.690

Review 7.  Health consequences of uninsurance among adults in the United States: recent evidence and implications.

Authors:  J Michael McWilliams
Journal:  Milbank Q       Date:  2009-06       Impact factor: 6.237

8.  A cross-sectional study of the microeconomic impact of cardiovascular disease hospitalization in four low- and middle-income countries.

Authors:  Mark D Huffman; Krishna D Rao; Andres Pichon-Riviere; Dong Zhao; S Harikrishnan; Kaushik Ramaiya; V S Ajay; Shifalika Goenka; Juan I Calcagno; Joaquín E Caporale; Shaoli Niu; Yan Li; Jing Liu; K R Thankappan; Meena Daivadanam; Jan van Esch; Adrianna Murphy; Andrew E Moran; Thomas A Gaziano; Marc Suhrcke; K Srinath Reddy; Stephen Leeder; Dorairaj Prabhakaran
Journal:  PLoS One       Date:  2011-06-14       Impact factor: 3.240

9.  High prevalence of hypertension and of risk factors for non-communicable diseases (NCDs): a population based cross-sectional survey of NCDS and HIV infection in Northwestern Tanzania and Southern Uganda.

Authors:  Bazil Kavishe; Samuel Biraro; Kathy Baisley; Fiona Vanobberghen; Saidi Kapiga; Paula Munderi; Liam Smeeth; Robert Peck; Janneth Mghamba; Gerald Mutungi; Eric Ikoona; Jonathan Levin; Maria Assumpció Bou Monclús; David Katende; Edmund Kisanga; Richard Hayes; Heiner Grosskurth
Journal:  BMC Med       Date:  2015-05-29       Impact factor: 8.775

10.  Cost-of-illness studies in heart failure: a systematic review 2004-2016.

Authors:  Wladimir Lesyuk; Christine Kriza; Peter Kolominsky-Rabas
Journal:  BMC Cardiovasc Disord       Date:  2018-05-02       Impact factor: 2.298

View more
  1 in total

1.  Women empowerment and health insurance utilisation in Rwanda: a nationwide cross-sectional survey.

Authors:  Joseph Kawuki; Ghislaine Gatasi; Quraish Sserwanja
Journal:  BMC Womens Health       Date:  2022-09-16       Impact factor: 2.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.